logo-loader
NASDAQ:ACOR

Acorda Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$129.89 m
Price
$2.70
Change
3.05%
52 weeks high
29.70
52 weeks low
2.29

In brief

Acorda Therapeutics is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.